Evidence map›Paper›PMID 38184627›Full record

ArticleNature communications2024

Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension.

Anna Ulrich, Yukyee Wu, Harmen Draisma, John Wharton, Emilia M Swietlik, Inês Cebola, Eleni Vasilaki, Zhanna Balkhiyarova, Marjo-Riitta Jarvelin, Juha Auvinen and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Cathepsin Z/X: Breaking Down the Known and Unknown.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Current Evidence on the Potential Role of EndothelialReviews in cardiovascular medicine · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 14 institutions in 4 countries.

Anna Ulrich *Department of Clinical and Experimental Medicine, University of Surrey, Surrey, UK.ORCID 0000-0003-3280-9974
Yukyee Wu *National Heart and Lung Institute, Imperial College London, London, UK.
Harmen DraismaDepartment of Clinical and Experimental Medicine, University of Surrey, Surrey, UK.ORCID 0000-0001-6279-0368
John WhartonNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-8110-2575
Emilia M SwietlikVPD Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Inês CebolaSection of Genetics & Genomics, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.ORCID 0000-0003-3528-4982
Eleni VasilakiNational Heart and Lung Institute, Imperial College London, London, UK.
Zhanna BalkhiyarovaDepartment of Clinical and Experimental Medicine, University of Surrey, Surrey, UK.
Marjo-Riitta JarvelinMRC Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID 0000-0002-2149-0630
Juha AuvinenCenter for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland.
Karl-Heinz HerzigInstitute of Biomedicine, Medical Research Center Oulu, Oulu University and Oulu University Hospital, Oulu, Finland.ORCID 0000-0003-4460-2604
J Gerry CoghlanUniversity College London, London, UK.
James LordanUniversity of Newcastle, Newcastle, UK.
Colin ChurchGolden Jubilee National Hospital and University of Glasgow, Glasgow, UK.
Luke S HowardNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-2822-210X
Joanna Pepke-ZabaRoyal Papworth Hospital, Cambridge, UK.
Mark ToshnerVPD Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
Stephen J WortNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-4287-1173
David G KielyDepartment of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Robin CondliffeDepartment of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Allan LawrieNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-4192-9505
Stefan GräfVPD Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1315-8873
Nicholas W MorrellVPD Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5700-9792
Martin R WilkinsNational Heart and Lung Institute, Imperial College London, London, UK.ORCID 0000-0003-3926-1171
Inga ProkopenkoDepartment of Clinical and Experimental Medicine, University of Surrey, Surrey, UK.ORCID 0000-0003-1624-7457
Christopher J RhodesNational Heart and Lung Institute, Imperial College London, London, UK. crhodes@ic.ac.uk.ORCID 0000-0002-4962-3204
Imperial College London · GBUniversity of Cambridge · GBUniversity of Surrey · GBRoyal Hallamshire Hospital · GBGenomics (United Kingdom) · GBGolden Jubilee National Hospital · GBLung Institute · USNewcastle University · GBOulu University Hospital · FIPapworth Hospital · GBPoznan University of Medical Sciences · PLRoyal Brompton Hospital · GBUniversity College London · GBUniversity of Oulu · FI

Funding

Academy of Medical Sciences SBF004\1095British Heart Foundation FS/SBSRF/22/31025Diabetes UK BDA number: 20/0006307Medical Research Council MR/K020919/1Wellcome Trust
6 · The paper itself

Abstract

Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular remodelling causing premature death from right heart failure. Established DNA variants influence PAH risk, but susceptibility from epigenetic changes is unknown. We addressed this through epigenome-wide association study (EWAS), testing 865,848 CpG sites for association with PAH in 429 individuals with PAH and 1226 controls. Three loci, at Cathepsin Z (CTSZ, cg04917472), Conserved oligomeric Golgi complex 6 (COG6, cg27396197), and Zinc Finger Protein 678 (ZNF678, cg03144189), reached epigenome-wide significance (p < 10

Indexed as

Pulmonary Arterial HypertensionBone Morphogenetic ProteinsCathepsin ZDNA MethylationEndothelial CellsFamilial Primary Pulmonary HypertensionHumansBMP10 protein, humanBone Morphogenetic ProteinsCathepsin ZCTSZ protein, human

Identifiers

PMID38184627
PMCPMC10771427
OpenAlexW4390637814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.